The partnership would help ophthalmologists enhance their skill-sets leading to better treatment outcome
L V Prasad Eye Institute (LVPEI) has entered into a partnership with DocMode to roll out its online CME initiative on Uveitis for the benefit of practicing ophthalmologists, across the world.
The partnership would help ophthalmologists enhance their skill-sets leading to better treatment outcome.
Hans Lewis, Founder & CEO, DocMode said, “LVPEI is a proven leader in ophthalmology. It has been doing a tremendous job in providing an equitable and efficient eye to all sections of the society. We are proud to be part of LVPEI’s CME initiatives and commitment to excellent eye care.”
The LVPEI Uveitis Series will help in identifying different patterns of Uveitis through clinical observations which in turn will lead to judicious use of laboratory investigations and treatment options resulting in excellent treatment outcome, added Lewis.
The LVPEI-DocMode partnership brings 12 courses; one program on anterior Uveitis, 3 programs on posterior Uveitis (Retinitis, Retinal Vasculitis, Choroditis), one program each on panuveitis, intermediate Uveitis, scleritis and episcleritis, ocular imaging in Uveitis, laboratory investigations in Uveitis and 3 programs on principles of treatment outcome (corticosteroids, infectious Uveitis, non-steroidal immunosuppressive therapy).
The courses offered in four sessions, spread over a month, each with 1 hour duration include topic overview, opportunity to listen to world leaders and access to special group meetings with Uveitis experts from major eye centres in the world like Los Angeles USA, Belo Horizonte, Brazil, Sydney, Australia. Participants completing the course successfully would receive a certificate, besides one MMC point.
Dr. Soumyava Basu, MS-Head Uveitis Service, LVPEI Network, DBT Wellcome Trust India Alliance Fellow, LVPEI, Hyderabad said, “The e-learning will foster participants to identify various clinical signs of Uveitis, classify it into broad groups for systematic management of patients, apply imaging tools in defining different patterns of intraocular inflammation, develop rational use of laboratory and radiological investigations and understand the application of diverse treatment choices in uveitis.”
He further added that those taking the session would be able to treat 90% patients with simple clinical logic.
This initiative is of particular importance to India since various studies put the incidence rate of uveitis in India at 783 per 100,000 persons – one of the highest in the world. “So, our goal is upscale the quality of eye care by equipping our healthcare professionals with the latest treatment techniques to treat various conditions including uveitis. This CME initiative is a step that direction,” added Dr. Basu.
- Advertisement -